Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Acquisitions & Divestments (2018 - 2022)

Historic Change in Acquisitions & Divestments for TransMedics (TMDX) over the last 4 years, with Q3 2022 value amounting to $28.7 million.

  • TransMedics' Change in Acquisitions & Divestments rose 424.0% to $28.7 million in Q3 2022 from the same period last year, while for Dec 2022 it was $76.9 million, marking a year-over-year decrease of 2661.39%. This contributed to the annual value of $76.9 million for FY2022, which is 2661.39% down from last year.
  • As of Q3 2022, TransMedics' Change in Acquisitions & Divestments stood at $28.7 million, which was up 424.0% from $33.8 million recorded in Q2 2022.
  • In the past 5 years, TransMedics' Change in Acquisitions & Divestments ranged from a high of $37.8 million in Q2 2021 and a low of $750000.0 during Q3 2018
  • Moreover, its 4-year median value for Change in Acquisitions & Divestments was $18.7 million (2020), whereas its average is $19.7 million.
  • Data for TransMedics' Change in Acquisitions & Divestments shows a peak YoY increase of 10042.41% (in 2021) and a maximum YoY decrease of 3867.47% (in 2021) over the last 5 years.
  • TransMedics' Change in Acquisitions & Divestments (Quarter) stood at $750000.0 in 2018, then surged by 3922.27% to $30.2 million in 2020, then tumbled by 38.67% to $18.5 million in 2021, then surged by 54.95% to $28.7 million in 2022.
  • Its Change in Acquisitions & Divestments was $28.7 million in Q3 2022, compared to $33.8 million in Q2 2022 and $14.5 million in Q1 2022.